Figure 2
Characterization of FGFR1/2+ skeletal cells in vivo. (A) Immunofluorescence of trabecular BM tissue section from anterior iliac visualized with confocal microscopy. A 3D reconstruction of a Z-stack of the whole 10-μm section taken at 0.3-μm intervals is shown. Hematopoietic lineage markers (Lin) and CD31 were used to exclude hematopoietic cells and endothelial cells, respectively. The dotted line shows a trabecular bone surface. (B) Whole-mount immunofluorescence staining of perichondrium (acquired as in Figure 1). Collagen 1 (Col.1) and PTHrP showed a similar expression pattern to FGFR1/2+ cells in the perichondrium and were sometimes irrigated by CD31+ microvasculature. (C) Cells surrounded by perichondrium-specific, FGF-18–expressing cells. The proliferation marker Ki67 was only detected in perichondrial cells and colocalized with FGFR1/2+ cells (D). (E) Three D reconstruction and surface rendering demonstrating that most periosteal FGFR1+ cells were pericytes wrapped around CD31+ blood vessels. In the mostly avascular perichondrium, the pericyte marker NG2 did not colocalize with FGFR1+ cells, but appeared to be expressed by chondrocytic progenitors (F). In vascularized periosteum, FGFR1+/NG2+ pericytes could be observed; however, not all FGFR1+ cells coexpressed NG2, which was also detected in nonpericytic cells (G). Expression of the pericytic MSC marker CD146 in periosteum also showed only limited colocalization with NG2 (H).

Characterization of FGFR1/2+ skeletal cells in vivo. (A) Immunofluorescence of trabecular BM tissue section from anterior iliac visualized with confocal microscopy. A 3D reconstruction of a Z-stack of the whole 10-μm section taken at 0.3-μm intervals is shown. Hematopoietic lineage markers (Lin) and CD31 were used to exclude hematopoietic cells and endothelial cells, respectively. The dotted line shows a trabecular bone surface. (B) Whole-mount immunofluorescence staining of perichondrium (acquired as in Figure 1). Collagen 1 (Col.1) and PTHrP showed a similar expression pattern to FGFR1/2+ cells in the perichondrium and were sometimes irrigated by CD31+ microvasculature. (C) Cells surrounded by perichondrium-specific, FGF-18–expressing cells. The proliferation marker Ki67 was only detected in perichondrial cells and colocalized with FGFR1/2+ cells (D). (E) Three D reconstruction and surface rendering demonstrating that most periosteal FGFR1+ cells were pericytes wrapped around CD31+ blood vessels. In the mostly avascular perichondrium, the pericyte marker NG2 did not colocalize with FGFR1+ cells, but appeared to be expressed by chondrocytic progenitors (F). In vascularized periosteum, FGFR1+/NG2+ pericytes could be observed; however, not all FGFR1+ cells coexpressed NG2, which was also detected in nonpericytic cells (G). Expression of the pericytic MSC marker CD146 in periosteum also showed only limited colocalization with NG2 (H).

Close Modal

or Create an Account

Close Modal
Close Modal